Previous close | 65.88 |
Open | 70.00 |
Bid | 67.81 x 200 |
Ask | 68.18 x 100 |
Day's range | 64.05 - 70.00 |
52-week range | 40.00 - 70.81 |
Volume | |
Avg. volume | 154,230 |
Market cap | 1.428B |
Beta (5Y monthly) | 0.81 |
PE ratio (TTM) | 80.06 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Highlights Include Record Net Revenues and Robust Growth in Rare Disease Segment
Nektar (NKTR) reports a narrower-than-expected loss in the first quarter of 2024 and tops revenue estimates.
Insmed (INSM) Q1 earnings beat estimates while sales miss the mark. Management posts positive data readouts from mid-stage studies on its experimental inhalation powder in PH-ILD and PAH indications.